Victory Capital Management Inc Lineage Cell Therapeutics, Inc. Transaction History

Victory Capital Management Inc

  • $95.7 Billion
  • Q4 2024

A detailed history of Victory Capital Management Inc transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 27,084 shares of LCTX stock, worth $13,812. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,084
Previous 23,865 13.49%
Holding current value
$13,812
Previous $21,000 38.1%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
BUY
$0.5 - $0.95 $1,609 - $3,058
3,219 Added 13.49%
27,084 $13,000
Q3 2024

Nov 05, 2024
SELL
$0.8 - $1.12 $332 - $464
-415 Reduced 1.71%
23,865 $21,000
Q2 2024

Aug 05, 2024
SELL
$0.89 - $1.47 $347 - $573
-390 Reduced 1.58%
24,280 $24,000
Q1 2024

May 03, 2024
BUY
$0.86 - $1.48 $1,010 - $1,739
1,175 Added 5.0%
24,670 $36,000
Q4 2023

Feb 05, 2024
BUY
$0.91 - $1.35 $3,881 - $5,757
4,265 Added 22.18%
23,495 $25,000
Q3 2023

Nov 06, 2023
BUY
$1.16 - $1.53 $932 - $1,230
804 Added 4.36%
19,230 $22,000
Q2 2023

Jul 27, 2023
SELL
$1.26 - $1.53 $539 - $654
-428 Reduced 2.27%
18,426 $25,000
Q1 2023

May 02, 2023
SELL
$1.2 - $1.53 $262 - $335
-219 Reduced 1.15%
18,854 $28,000
Q4 2022

Feb 09, 2023
SELL
$1.02 - $1.5 $7 - $10
-7 Reduced 0.04%
19,073 $22,000
Q3 2022

Nov 02, 2022
SELL
$1.13 - $1.77 $4,035 - $6,320
-3,571 Reduced 15.77%
19,080 $22,000
Q2 2022

Aug 01, 2022
BUY
$1.12 - $1.61 $269 - $388
241 Added 1.08%
22,651 $36,000
Q1 2022

May 04, 2022
SELL
$1.21 - $2.48 $1,366 - $2,799
-1,129 Reduced 4.8%
22,410 $27,000
Q4 2021

Feb 07, 2022
SELL
$1.84 - $2.68 $1,056 - $1,538
-574 Reduced 2.38%
23,539 $58,000
Q3 2021

Nov 02, 2021
SELL
$2.26 - $2.86 $935 - $1,184
-414 Reduced 1.69%
24,113 $61,000
Q2 2021

Aug 03, 2021
BUY
$2.17 - $3.0 $2,458 - $3,399
1,133 Added 4.84%
24,527 $70,000
Q1 2021

May 04, 2021
SELL
$1.77 - $3.1 $1,288 - $2,256
-728 Reduced 3.02%
23,394 $55,000
Q4 2020

Feb 01, 2021
BUY
$0.95 - $1.83 $1,171 - $2,256
1,233 Added 5.39%
24,122 $42,000
Q3 2020

Nov 09, 2020
SELL
$0.75 - $1.09 $970 - $1,410
-1,294 Reduced 5.35%
22,889 $21,000
Q2 2020

Aug 07, 2020
SELL
$0.71 - $1.18 $516 - $857
-727 Reduced 2.92%
24,183 $21,000
Q1 2020

May 04, 2020
SELL
$0.6 - $1.58 $338 - $891
-564 Reduced 2.21%
24,910 $21,000
Q4 2019

Feb 04, 2020
SELL
$0.54 - $1.01 $212 - $396
-393 Reduced 1.52%
25,474 $26,000
Q3 2019

Nov 12, 2019
BUY
$0.85 - $1.24 $21,986 - $32,075
25,867 New
25,867 $25,000

Others Institutions Holding LCTX

# of Institutions
135
Shares Held
106M
Call Options Held
22.1K
Put Options Held
0
View Full List

About Lineage Cell Therapeutics, Inc.

LCTX Quotes by TradingView
  • Ticker LCTX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 169,755,008
  • Market Cap $86.6M
  • Description
  • Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...
More about LCTX
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email